ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Regulatory T Cell Tregs Therapies Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-35R13920
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Regulatory T Cell Tregs Therapies Market Research Report 2023
BUY CHAPTERS

Global Regulatory T Cell Tregs Therapies Market Research Report 2025

Code: QYRE-Auto-35R13920
Report
May 2025
Pages:92
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Coya Therapeutics
Roche
Caladrius Biosciences
Nektar Therapeutics
Eli Lilly and Company
Miltenyi Biotec
Amgen Inc
Pfizer Inc
Parvus Therapeutics
Celgene
Abata Therapeutics
Cellenkos Inc
Sonoma Biotherapeutics
Regimmune
Teraimmune
Tract Therapeutics
Vt Bio
Sangamo Therapeutics (Txcell)
Poltreg Sa

Regulatory T Cell Tregs Therapies Market

The global market for Regulatory T Cell Tregs Therapies was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Regulatory T Cell Tregs Therapies is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Regulatory T Cell Tregs Therapies is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Regulatory T Cell Tregs Therapies in Hospital is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Regulatory T Cell Tregs Therapies include Abata Therapeutics, Cellenkos Inc, Coya Therapeutics, Roche, Caladrius Biosciences, Sonoma Biotherapeutics, Nektar Therapeutics, Eli Lilly And Company, Regimmune, Miltenyi Biotec, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Regulatory T Cell Tregs Therapies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Regulatory T Cell Tregs Therapies.
The Regulatory T Cell Tregs Therapies market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Regulatory T Cell Tregs Therapies market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Regulatory T Cell Tregs Therapies companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Regulatory T Cell Tregs Therapies Market Report

Report Metric Details
Report Name Regulatory T Cell Tregs Therapies Market
Segment by Type
Segment by Application
  • Hospital
  • Clinic
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Abata Therapeutics, Cellenkos Inc, Coya Therapeutics, Roche, Caladrius Biosciences, Sonoma Biotherapeutics, Nektar Therapeutics, Eli Lilly And Company, Regimmune, Miltenyi Biotec, Teraimmune, Tract Therapeutics, Vt Bio, Amgen, Sangamo Therapeutics (Txcell), Pfizer Inc, Poltreg Sa, Parvus Therapeutics, Celgene
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Regulatory T Cell Tregs Therapies company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Regulatory T Cell Tregs Therapies Market report?

Ans: The main players in the Regulatory T Cell Tregs Therapies Market are Abata Therapeutics, Cellenkos Inc, Coya Therapeutics, Roche, Caladrius Biosciences, Sonoma Biotherapeutics, Nektar Therapeutics, Eli Lilly And Company, Regimmune, Miltenyi Biotec, Teraimmune, Tract Therapeutics, Vt Bio, Amgen, Sangamo Therapeutics (Txcell), Pfizer Inc, Poltreg Sa, Parvus Therapeutics, Celgene

What are the Application segmentation covered in the Regulatory T Cell Tregs Therapies Market report?

Ans: The Applications covered in the Regulatory T Cell Tregs Therapies Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Regulatory T Cell Tregs Therapies Market report?

Ans: The Types covered in the Regulatory T Cell Tregs Therapies Market report are Tregs, Interleukin 2, Monoclonal Antibodies, Others

Recommended Reports

Cell Therapy Markets

T-Cell Therapeutics

Autoimmune Disease Treatment

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Regulatory T Cell Tregs Therapies Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Tregs
1.2.3 Interleukin 2
1.2.4 Monoclonal Antibodies
1.2.5 Others
1.3 Market by Application
1.3.1 Global Regulatory T Cell Tregs Therapies Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Regulatory T Cell Tregs Therapies Market Perspective (2020-2031)
2.2 Global Regulatory T Cell Tregs Therapies Growth Trends by Region
2.2.1 Global Regulatory T Cell Tregs Therapies Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Regulatory T Cell Tregs Therapies Historic Market Size by Region (2020-2025)
2.2.3 Regulatory T Cell Tregs Therapies Forecasted Market Size by Region (2026-2031)
2.3 Regulatory T Cell Tregs Therapies Market Dynamics
2.3.1 Regulatory T Cell Tregs Therapies Industry Trends
2.3.2 Regulatory T Cell Tregs Therapies Market Drivers
2.3.3 Regulatory T Cell Tregs Therapies Market Challenges
2.3.4 Regulatory T Cell Tregs Therapies Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Regulatory T Cell Tregs Therapies Players by Revenue
3.1.1 Global Top Regulatory T Cell Tregs Therapies Players by Revenue (2020-2025)
3.1.2 Global Regulatory T Cell Tregs Therapies Revenue Market Share by Players (2020-2025)
3.2 Global Regulatory T Cell Tregs Therapies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Regulatory T Cell Tregs Therapies Revenue
3.4 Global Regulatory T Cell Tregs Therapies Market Concentration Ratio
3.4.1 Global Regulatory T Cell Tregs Therapies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Regulatory T Cell Tregs Therapies Revenue in 2024
3.5 Global Key Players of Regulatory T Cell Tregs Therapies Head office and Area Served
3.6 Global Key Players of Regulatory T Cell Tregs Therapies, Product and Application
3.7 Global Key Players of Regulatory T Cell Tregs Therapies, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Regulatory T Cell Tregs Therapies Breakdown Data by Type
4.1 Global Regulatory T Cell Tregs Therapies Historic Market Size by Type (2020-2025)
4.2 Global Regulatory T Cell Tregs Therapies Forecasted Market Size by Type (2026-2031)
5 Regulatory T Cell Tregs Therapies Breakdown Data by Application
5.1 Global Regulatory T Cell Tregs Therapies Historic Market Size by Application (2020-2025)
5.2 Global Regulatory T Cell Tregs Therapies Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Regulatory T Cell Tregs Therapies Market Size (2020-2031)
6.2 North America Regulatory T Cell Tregs Therapies Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Regulatory T Cell Tregs Therapies Market Size by Country (2020-2025)
6.4 North America Regulatory T Cell Tregs Therapies Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Regulatory T Cell Tregs Therapies Market Size (2020-2031)
7.2 Europe Regulatory T Cell Tregs Therapies Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Regulatory T Cell Tregs Therapies Market Size by Country (2020-2025)
7.4 Europe Regulatory T Cell Tregs Therapies Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Regulatory T Cell Tregs Therapies Market Size (2020-2031)
8.2 Asia-Pacific Regulatory T Cell Tregs Therapies Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Regulatory T Cell Tregs Therapies Market Size by Region (2020-2025)
8.4 Asia-Pacific Regulatory T Cell Tregs Therapies Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Regulatory T Cell Tregs Therapies Market Size (2020-2031)
9.2 Latin America Regulatory T Cell Tregs Therapies Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Regulatory T Cell Tregs Therapies Market Size by Country (2020-2025)
9.4 Latin America Regulatory T Cell Tregs Therapies Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Regulatory T Cell Tregs Therapies Market Size (2020-2031)
10.2 Middle East & Africa Regulatory T Cell Tregs Therapies Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Regulatory T Cell Tregs Therapies Market Size by Country (2020-2025)
10.4 Middle East & Africa Regulatory T Cell Tregs Therapies Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abata Therapeutics
11.1.1 Abata Therapeutics Company Details
11.1.2 Abata Therapeutics Business Overview
11.1.3 Abata Therapeutics Regulatory T Cell Tregs Therapies Introduction
11.1.4 Abata Therapeutics Revenue in Regulatory T Cell Tregs Therapies Business (2020-2025)
11.1.5 Abata Therapeutics Recent Development
11.2 Cellenkos Inc
11.2.1 Cellenkos Inc Company Details
11.2.2 Cellenkos Inc Business Overview
11.2.3 Cellenkos Inc Regulatory T Cell Tregs Therapies Introduction
11.2.4 Cellenkos Inc Revenue in Regulatory T Cell Tregs Therapies Business (2020-2025)
11.2.5 Cellenkos Inc Recent Development
11.3 Coya Therapeutics
11.3.1 Coya Therapeutics Company Details
11.3.2 Coya Therapeutics Business Overview
11.3.3 Coya Therapeutics Regulatory T Cell Tregs Therapies Introduction
11.3.4 Coya Therapeutics Revenue in Regulatory T Cell Tregs Therapies Business (2020-2025)
11.3.5 Coya Therapeutics Recent Development
11.4 Roche
11.4.1 Roche Company Details
11.4.2 Roche Business Overview
11.4.3 Roche Regulatory T Cell Tregs Therapies Introduction
11.4.4 Roche Revenue in Regulatory T Cell Tregs Therapies Business (2020-2025)
11.4.5 Roche Recent Development
11.5 Caladrius Biosciences
11.5.1 Caladrius Biosciences Company Details
11.5.2 Caladrius Biosciences Business Overview
11.5.3 Caladrius Biosciences Regulatory T Cell Tregs Therapies Introduction
11.5.4 Caladrius Biosciences Revenue in Regulatory T Cell Tregs Therapies Business (2020-2025)
11.5.5 Caladrius Biosciences Recent Development
11.6 Sonoma Biotherapeutics
11.6.1 Sonoma Biotherapeutics Company Details
11.6.2 Sonoma Biotherapeutics Business Overview
11.6.3 Sonoma Biotherapeutics Regulatory T Cell Tregs Therapies Introduction
11.6.4 Sonoma Biotherapeutics Revenue in Regulatory T Cell Tregs Therapies Business (2020-2025)
11.6.5 Sonoma Biotherapeutics Recent Development
11.7 Nektar Therapeutics
11.7.1 Nektar Therapeutics Company Details
11.7.2 Nektar Therapeutics Business Overview
11.7.3 Nektar Therapeutics Regulatory T Cell Tregs Therapies Introduction
11.7.4 Nektar Therapeutics Revenue in Regulatory T Cell Tregs Therapies Business (2020-2025)
11.7.5 Nektar Therapeutics Recent Development
11.8 Eli Lilly And Company
11.8.1 Eli Lilly And Company Company Details
11.8.2 Eli Lilly And Company Business Overview
11.8.3 Eli Lilly And Company Regulatory T Cell Tregs Therapies Introduction
11.8.4 Eli Lilly And Company Revenue in Regulatory T Cell Tregs Therapies Business (2020-2025)
11.8.5 Eli Lilly And Company Recent Development
11.9 Regimmune
11.9.1 Regimmune Company Details
11.9.2 Regimmune Business Overview
11.9.3 Regimmune Regulatory T Cell Tregs Therapies Introduction
11.9.4 Regimmune Revenue in Regulatory T Cell Tregs Therapies Business (2020-2025)
11.9.5 Regimmune Recent Development
11.10 Miltenyi Biotec
11.10.1 Miltenyi Biotec Company Details
11.10.2 Miltenyi Biotec Business Overview
11.10.3 Miltenyi Biotec Regulatory T Cell Tregs Therapies Introduction
11.10.4 Miltenyi Biotec Revenue in Regulatory T Cell Tregs Therapies Business (2020-2025)
11.10.5 Miltenyi Biotec Recent Development
11.11 Teraimmune
11.11.1 Teraimmune Company Details
11.11.2 Teraimmune Business Overview
11.11.3 Teraimmune Regulatory T Cell Tregs Therapies Introduction
11.11.4 Teraimmune Revenue in Regulatory T Cell Tregs Therapies Business (2020-2025)
11.11.5 Teraimmune Recent Development
11.12 Tract Therapeutics
11.12.1 Tract Therapeutics Company Details
11.12.2 Tract Therapeutics Business Overview
11.12.3 Tract Therapeutics Regulatory T Cell Tregs Therapies Introduction
11.12.4 Tract Therapeutics Revenue in Regulatory T Cell Tregs Therapies Business (2020-2025)
11.12.5 Tract Therapeutics Recent Development
11.13 Vt Bio
11.13.1 Vt Bio Company Details
11.13.2 Vt Bio Business Overview
11.13.3 Vt Bio Regulatory T Cell Tregs Therapies Introduction
11.13.4 Vt Bio Revenue in Regulatory T Cell Tregs Therapies Business (2020-2025)
11.13.5 Vt Bio Recent Development
11.14 Amgen
11.14.1 Amgen Company Details
11.14.2 Amgen Business Overview
11.14.3 Amgen Regulatory T Cell Tregs Therapies Introduction
11.14.4 Amgen Revenue in Regulatory T Cell Tregs Therapies Business (2020-2025)
11.14.5 Amgen Recent Development
11.15 Sangamo Therapeutics (Txcell)
11.15.1 Sangamo Therapeutics (Txcell) Company Details
11.15.2 Sangamo Therapeutics (Txcell) Business Overview
11.15.3 Sangamo Therapeutics (Txcell) Regulatory T Cell Tregs Therapies Introduction
11.15.4 Sangamo Therapeutics (Txcell) Revenue in Regulatory T Cell Tregs Therapies Business (2020-2025)
11.15.5 Sangamo Therapeutics (Txcell) Recent Development
11.16 Pfizer Inc
11.16.1 Pfizer Inc Company Details
11.16.2 Pfizer Inc Business Overview
11.16.3 Pfizer Inc Regulatory T Cell Tregs Therapies Introduction
11.16.4 Pfizer Inc Revenue in Regulatory T Cell Tregs Therapies Business (2020-2025)
11.16.5 Pfizer Inc Recent Development
11.17 Poltreg Sa
11.17.1 Poltreg Sa Company Details
11.17.2 Poltreg Sa Business Overview
11.17.3 Poltreg Sa Regulatory T Cell Tregs Therapies Introduction
11.17.4 Poltreg Sa Revenue in Regulatory T Cell Tregs Therapies Business (2020-2025)
11.17.5 Poltreg Sa Recent Development
11.18 Parvus Therapeutics
11.18.1 Parvus Therapeutics Company Details
11.18.2 Parvus Therapeutics Business Overview
11.18.3 Parvus Therapeutics Regulatory T Cell Tregs Therapies Introduction
11.18.4 Parvus Therapeutics Revenue in Regulatory T Cell Tregs Therapies Business (2020-2025)
11.18.5 Parvus Therapeutics Recent Development
11.19 Celgene
11.19.1 Celgene Company Details
11.19.2 Celgene Business Overview
11.19.3 Celgene Regulatory T Cell Tregs Therapies Introduction
11.19.4 Celgene Revenue in Regulatory T Cell Tregs Therapies Business (2020-2025)
11.19.5 Celgene Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Coya Therapeutics
Roche
Caladrius Biosciences
Nektar Therapeutics
Eli Lilly and Company
Miltenyi Biotec
Amgen Inc
Pfizer Inc
Parvus Therapeutics
Celgene
Abata Therapeutics
Cellenkos Inc
Sonoma Biotherapeutics
Regimmune
Teraimmune
Tract Therapeutics
Vt Bio
Sangamo Therapeutics (Txcell)
Poltreg Sa
List of Tables
 Table 1. Global Regulatory T Cell Tregs Therapies Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Tregs
 Table 3. Key Players of Interleukin 2
 Table 4. Key Players of Monoclonal Antibodies
 Table 5. Key Players of Others
 Table 6. Global Regulatory T Cell Tregs Therapies Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Regulatory T Cell Tregs Therapies Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Regulatory T Cell Tregs Therapies Market Size by Region (2020-2025) & (US$ Million)
 Table 9. Global Regulatory T Cell Tregs Therapies Market Share by Region (2020-2025)
 Table 10. Global Regulatory T Cell Tregs Therapies Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 11. Global Regulatory T Cell Tregs Therapies Market Share by Region (2026-2031)
 Table 12. Regulatory T Cell Tregs Therapies Market Trends
 Table 13. Regulatory T Cell Tregs Therapies Market Drivers
 Table 14. Regulatory T Cell Tregs Therapies Market Challenges
 Table 15. Regulatory T Cell Tregs Therapies Market Restraints
 Table 16. Global Regulatory T Cell Tregs Therapies Revenue by Players (2020-2025) & (US$ Million)
 Table 17. Global Regulatory T Cell Tregs Therapies Market Share by Players (2020-2025)
 Table 18. Global Top Regulatory T Cell Tregs Therapies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Regulatory T Cell Tregs Therapies as of 2024)
 Table 19. Ranking of Global Top Regulatory T Cell Tregs Therapies Companies by Revenue (US$ Million) in 2024
 Table 20. Global 5 Largest Players Market Share by Regulatory T Cell Tregs Therapies Revenue (CR5 and HHI) & (2020-2025)
 Table 21. Global Key Players of Regulatory T Cell Tregs Therapies, Headquarters and Area Served
 Table 22. Global Key Players of Regulatory T Cell Tregs Therapies, Product and Application
 Table 23. Global Key Players of Regulatory T Cell Tregs Therapies, Date of Enter into This Industry
 Table 24. Mergers & Acquisitions, Expansion Plans
 Table 25. Global Regulatory T Cell Tregs Therapies Market Size by Type (2020-2025) & (US$ Million)
 Table 26. Global Regulatory T Cell Tregs Therapies Revenue Market Share by Type (2020-2025)
 Table 27. Global Regulatory T Cell Tregs Therapies Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 28. Global Regulatory T Cell Tregs Therapies Revenue Market Share by Type (2026-2031)
 Table 29. Global Regulatory T Cell Tregs Therapies Market Size by Application (2020-2025) & (US$ Million)
 Table 30. Global Regulatory T Cell Tregs Therapies Revenue Market Share by Application (2020-2025)
 Table 31. Global Regulatory T Cell Tregs Therapies Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 32. Global Regulatory T Cell Tregs Therapies Revenue Market Share by Application (2026-2031)
 Table 33. North America Regulatory T Cell Tregs Therapies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 34. North America Regulatory T Cell Tregs Therapies Market Size by Country (2020-2025) & (US$ Million)
 Table 35. North America Regulatory T Cell Tregs Therapies Market Size by Country (2026-2031) & (US$ Million)
 Table 36. Europe Regulatory T Cell Tregs Therapies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 37. Europe Regulatory T Cell Tregs Therapies Market Size by Country (2020-2025) & (US$ Million)
 Table 38. Europe Regulatory T Cell Tregs Therapies Market Size by Country (2026-2031) & (US$ Million)
 Table 39. Asia-Pacific Regulatory T Cell Tregs Therapies Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 40. Asia-Pacific Regulatory T Cell Tregs Therapies Market Size by Region (2020-2025) & (US$ Million)
 Table 41. Asia-Pacific Regulatory T Cell Tregs Therapies Market Size by Region (2026-2031) & (US$ Million)
 Table 42. Latin America Regulatory T Cell Tregs Therapies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Latin America Regulatory T Cell Tregs Therapies Market Size by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Regulatory T Cell Tregs Therapies Market Size by Country (2026-2031) & (US$ Million)
 Table 45. Middle East & Africa Regulatory T Cell Tregs Therapies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Middle East & Africa Regulatory T Cell Tregs Therapies Market Size by Country (2020-2025) & (US$ Million)
 Table 47. Middle East & Africa Regulatory T Cell Tregs Therapies Market Size by Country (2026-2031) & (US$ Million)
 Table 48. Abata Therapeutics Company Details
 Table 49. Abata Therapeutics Business Overview
 Table 50. Abata Therapeutics Regulatory T Cell Tregs Therapies Product
 Table 51. Abata Therapeutics Revenue in Regulatory T Cell Tregs Therapies Business (2020-2025) & (US$ Million)
 Table 52. Abata Therapeutics Recent Development
 Table 53. Cellenkos Inc Company Details
 Table 54. Cellenkos Inc Business Overview
 Table 55. Cellenkos Inc Regulatory T Cell Tregs Therapies Product
 Table 56. Cellenkos Inc Revenue in Regulatory T Cell Tregs Therapies Business (2020-2025) & (US$ Million)
 Table 57. Cellenkos Inc Recent Development
 Table 58. Coya Therapeutics Company Details
 Table 59. Coya Therapeutics Business Overview
 Table 60. Coya Therapeutics Regulatory T Cell Tregs Therapies Product
 Table 61. Coya Therapeutics Revenue in Regulatory T Cell Tregs Therapies Business (2020-2025) & (US$ Million)
 Table 62. Coya Therapeutics Recent Development
 Table 63. Roche Company Details
 Table 64. Roche Business Overview
 Table 65. Roche Regulatory T Cell Tregs Therapies Product
 Table 66. Roche Revenue in Regulatory T Cell Tregs Therapies Business (2020-2025) & (US$ Million)
 Table 67. Roche Recent Development
 Table 68. Caladrius Biosciences Company Details
 Table 69. Caladrius Biosciences Business Overview
 Table 70. Caladrius Biosciences Regulatory T Cell Tregs Therapies Product
 Table 71. Caladrius Biosciences Revenue in Regulatory T Cell Tregs Therapies Business (2020-2025) & (US$ Million)
 Table 72. Caladrius Biosciences Recent Development
 Table 73. Sonoma Biotherapeutics Company Details
 Table 74. Sonoma Biotherapeutics Business Overview
 Table 75. Sonoma Biotherapeutics Regulatory T Cell Tregs Therapies Product
 Table 76. Sonoma Biotherapeutics Revenue in Regulatory T Cell Tregs Therapies Business (2020-2025) & (US$ Million)
 Table 77. Sonoma Biotherapeutics Recent Development
 Table 78. Nektar Therapeutics Company Details
 Table 79. Nektar Therapeutics Business Overview
 Table 80. Nektar Therapeutics Regulatory T Cell Tregs Therapies Product
 Table 81. Nektar Therapeutics Revenue in Regulatory T Cell Tregs Therapies Business (2020-2025) & (US$ Million)
 Table 82. Nektar Therapeutics Recent Development
 Table 83. Eli Lilly And Company Company Details
 Table 84. Eli Lilly And Company Business Overview
 Table 85. Eli Lilly And Company Regulatory T Cell Tregs Therapies Product
 Table 86. Eli Lilly And Company Revenue in Regulatory T Cell Tregs Therapies Business (2020-2025) & (US$ Million)
 Table 87. Eli Lilly And Company Recent Development
 Table 88. Regimmune Company Details
 Table 89. Regimmune Business Overview
 Table 90. Regimmune Regulatory T Cell Tregs Therapies Product
 Table 91. Regimmune Revenue in Regulatory T Cell Tregs Therapies Business (2020-2025) & (US$ Million)
 Table 92. Regimmune Recent Development
 Table 93. Miltenyi Biotec Company Details
 Table 94. Miltenyi Biotec Business Overview
 Table 95. Miltenyi Biotec Regulatory T Cell Tregs Therapies Product
 Table 96. Miltenyi Biotec Revenue in Regulatory T Cell Tregs Therapies Business (2020-2025) & (US$ Million)
 Table 97. Miltenyi Biotec Recent Development
 Table 98. Teraimmune Company Details
 Table 99. Teraimmune Business Overview
 Table 100. Teraimmune Regulatory T Cell Tregs Therapies Product
 Table 101. Teraimmune Revenue in Regulatory T Cell Tregs Therapies Business (2020-2025) & (US$ Million)
 Table 102. Teraimmune Recent Development
 Table 103. Tract Therapeutics Company Details
 Table 104. Tract Therapeutics Business Overview
 Table 105. Tract Therapeutics Regulatory T Cell Tregs Therapies Product
 Table 106. Tract Therapeutics Revenue in Regulatory T Cell Tregs Therapies Business (2020-2025) & (US$ Million)
 Table 107. Tract Therapeutics Recent Development
 Table 108. Vt Bio Company Details
 Table 109. Vt Bio Business Overview
 Table 110. Vt Bio Regulatory T Cell Tregs Therapies Product
 Table 111. Vt Bio Revenue in Regulatory T Cell Tregs Therapies Business (2020-2025) & (US$ Million)
 Table 112. Vt Bio Recent Development
 Table 113. Amgen Company Details
 Table 114. Amgen Business Overview
 Table 115. Amgen Regulatory T Cell Tregs Therapies Product
 Table 116. Amgen Revenue in Regulatory T Cell Tregs Therapies Business (2020-2025) & (US$ Million)
 Table 117. Amgen Recent Development
 Table 118. Sangamo Therapeutics (Txcell) Company Details
 Table 119. Sangamo Therapeutics (Txcell) Business Overview
 Table 120. Sangamo Therapeutics (Txcell) Regulatory T Cell Tregs Therapies Product
 Table 121. Sangamo Therapeutics (Txcell) Revenue in Regulatory T Cell Tregs Therapies Business (2020-2025) & (US$ Million)
 Table 122. Sangamo Therapeutics (Txcell) Recent Development
 Table 123. Pfizer Inc Company Details
 Table 124. Pfizer Inc Business Overview
 Table 125. Pfizer Inc Regulatory T Cell Tregs Therapies Product
 Table 126. Pfizer Inc Revenue in Regulatory T Cell Tregs Therapies Business (2020-2025) & (US$ Million)
 Table 127. Pfizer Inc Recent Development
 Table 128. Poltreg Sa Company Details
 Table 129. Poltreg Sa Business Overview
 Table 130. Poltreg Sa Regulatory T Cell Tregs Therapies Product
 Table 131. Poltreg Sa Revenue in Regulatory T Cell Tregs Therapies Business (2020-2025) & (US$ Million)
 Table 132. Poltreg Sa Recent Development
 Table 133. Parvus Therapeutics Company Details
 Table 134. Parvus Therapeutics Business Overview
 Table 135. Parvus Therapeutics Regulatory T Cell Tregs Therapies Product
 Table 136. Parvus Therapeutics Revenue in Regulatory T Cell Tregs Therapies Business (2020-2025) & (US$ Million)
 Table 137. Parvus Therapeutics Recent Development
 Table 138. Celgene Company Details
 Table 139. Celgene Business Overview
 Table 140. Celgene Regulatory T Cell Tregs Therapies Product
 Table 141. Celgene Revenue in Regulatory T Cell Tregs Therapies Business (2020-2025) & (US$ Million)
 Table 142. Celgene Recent Development
 Table 143. Research Programs/Design for This Report
 Table 144. Key Data Information from Secondary Sources
 Table 145. Key Data Information from Primary Sources
 Table 146. Authors List of This Report


List of Figures
 Figure 1. Regulatory T Cell Tregs Therapies Picture
 Figure 2. Global Regulatory T Cell Tregs Therapies Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Regulatory T Cell Tregs Therapies Market Share by Type: 2024 VS 2031
 Figure 4. Tregs Features
 Figure 5. Interleukin 2 Features
 Figure 6. Monoclonal Antibodies Features
 Figure 7. Others Features
 Figure 8. Global Regulatory T Cell Tregs Therapies Market Size by Application (2020-2031) & (US$ Million)
 Figure 9. Global Regulatory T Cell Tregs Therapies Market Share by Application: 2024 VS 2031
 Figure 10. Hospital Case Studies
 Figure 11. Clinic Case Studies
 Figure 12. Others Case Studies
 Figure 13. Regulatory T Cell Tregs Therapies Report Years Considered
 Figure 14. Global Regulatory T Cell Tregs Therapies Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 15. Global Regulatory T Cell Tregs Therapies Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Regulatory T Cell Tregs Therapies Market Share by Region: 2024 VS 2031
 Figure 17. Global Regulatory T Cell Tregs Therapies Market Share by Players in 2024
 Figure 18. Global Top Regulatory T Cell Tregs Therapies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Regulatory T Cell Tregs Therapies as of 2024)
 Figure 19. The Top 10 and 5 Players Market Share by Regulatory T Cell Tregs Therapies Revenue in 2024
 Figure 20. North America Regulatory T Cell Tregs Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. North America Regulatory T Cell Tregs Therapies Market Share by Country (2020-2031)
 Figure 22. United States Regulatory T Cell Tregs Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Canada Regulatory T Cell Tregs Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Regulatory T Cell Tregs Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Regulatory T Cell Tregs Therapies Market Share by Country (2020-2031)
 Figure 26. Germany Regulatory T Cell Tregs Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. France Regulatory T Cell Tregs Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. U.K. Regulatory T Cell Tregs Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Italy Regulatory T Cell Tregs Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Russia Regulatory T Cell Tregs Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Nordic Countries Regulatory T Cell Tregs Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Regulatory T Cell Tregs Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Regulatory T Cell Tregs Therapies Market Share by Region (2020-2031)
 Figure 34. China Regulatory T Cell Tregs Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Japan Regulatory T Cell Tregs Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. South Korea Regulatory T Cell Tregs Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Southeast Asia Regulatory T Cell Tregs Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. India Regulatory T Cell Tregs Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Australia Regulatory T Cell Tregs Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Regulatory T Cell Tregs Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Regulatory T Cell Tregs Therapies Market Share by Country (2020-2031)
 Figure 42. Mexico Regulatory T Cell Tregs Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Brazil Regulatory T Cell Tregs Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Regulatory T Cell Tregs Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Regulatory T Cell Tregs Therapies Market Share by Country (2020-2031)
 Figure 46. Turkey Regulatory T Cell Tregs Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Saudi Arabia Regulatory T Cell Tregs Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. UAE Regulatory T Cell Tregs Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Abata Therapeutics Revenue Growth Rate in Regulatory T Cell Tregs Therapies Business (2020-2025)
 Figure 50. Cellenkos Inc Revenue Growth Rate in Regulatory T Cell Tregs Therapies Business (2020-2025)
 Figure 51. Coya Therapeutics Revenue Growth Rate in Regulatory T Cell Tregs Therapies Business (2020-2025)
 Figure 52. Roche Revenue Growth Rate in Regulatory T Cell Tregs Therapies Business (2020-2025)
 Figure 53. Caladrius Biosciences Revenue Growth Rate in Regulatory T Cell Tregs Therapies Business (2020-2025)
 Figure 54. Sonoma Biotherapeutics Revenue Growth Rate in Regulatory T Cell Tregs Therapies Business (2020-2025)
 Figure 55. Nektar Therapeutics Revenue Growth Rate in Regulatory T Cell Tregs Therapies Business (2020-2025)
 Figure 56. Eli Lilly And Company Revenue Growth Rate in Regulatory T Cell Tregs Therapies Business (2020-2025)
 Figure 57. Regimmune Revenue Growth Rate in Regulatory T Cell Tregs Therapies Business (2020-2025)
 Figure 58. Miltenyi Biotec Revenue Growth Rate in Regulatory T Cell Tregs Therapies Business (2020-2025)
 Figure 59. Teraimmune Revenue Growth Rate in Regulatory T Cell Tregs Therapies Business (2020-2025)
 Figure 60. Tract Therapeutics Revenue Growth Rate in Regulatory T Cell Tregs Therapies Business (2020-2025)
 Figure 61. Vt Bio Revenue Growth Rate in Regulatory T Cell Tregs Therapies Business (2020-2025)
 Figure 62. Amgen Revenue Growth Rate in Regulatory T Cell Tregs Therapies Business (2020-2025)
 Figure 63. Sangamo Therapeutics (Txcell) Revenue Growth Rate in Regulatory T Cell Tregs Therapies Business (2020-2025)
 Figure 64. Pfizer Inc Revenue Growth Rate in Regulatory T Cell Tregs Therapies Business (2020-2025)
 Figure 65. Poltreg Sa Revenue Growth Rate in Regulatory T Cell Tregs Therapies Business (2020-2025)
 Figure 66. Parvus Therapeutics Revenue Growth Rate in Regulatory T Cell Tregs Therapies Business (2020-2025)
 Figure 67. Celgene Revenue Growth Rate in Regulatory T Cell Tregs Therapies Business (2020-2025)
 Figure 68. Bottom-up and Top-down Approaches for This Report
 Figure 69. Data Triangulation
 Figure 70. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano String

SIMILAR REPORTS

Global Novel T Cell Immunotherapies Market Research Report 2024
Global TCR T Therapy Market Research Report 2024
Global T Cell Transfer Therapy Market Research Report 2024
Global Cell Based Immunotherapy Market Research Report 2024
Global Cell Based Regenerative Therapy Market Research Report 2024
Global CAR T Therapy Market Research Report 2024
Global Chimeric Antigen Receptor T Cell Therapy Market Research Report 2024
Global Cardiac Disease Stem Cell Therapy Market Research Report 2024
Global Epigenetic Therapeutics Market Research Report 2024
Global Disc Disease Stem Cell Therapy Market Research Report 2024
Gamma Delta T Cell Cancer Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Tissue Regenerative Therapy Market Research Report 2024
Global TCR T Therapy Reagent Market Insights Forecast to 2030
Global Aldult CAR T cell Therapy Market Research Report 2024
Global Nivolumab Market Research Report 2024
Global TIGIT Therapies Market Research Report 2024
TCR Based Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Cell Therapy Manufacturing Market Research Report 2025
Global Cell Reprogramming Market Research Report 2025
Global Liver Stem Cell Therapy Market Research Report 2024

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions